Diabetes Mellitus/diagnosis/*drug therapy/epidemiology Dose-Response Relationship Drug Humans Hypoglycemic Agents/*adverse effects Linear Models Multivariate Analysis Odds Ratio Pioglitazone Risk Assessment Risk Factors Thiazolidinediones/*adverse effects Time Factors Urinary Bladder Neoplasms/*chemically induced/diagnosis/epidemiology

Ki-67 bladder cancer meta-analysis prognosis urothelial carcinoma

PSCA 膀胱癌 基因多态性 Meta分析

Adjuvants Immunologic/administration & dosage Administration Intravesical Antineoplastic Agents/therapeutic use BCG Vaccine/*administration & dosage Bayes Theorem Disease Progression Humans Immunotherapy/*methods Incidence Neoplasm Recurrence Local/drug therapy Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/*drug therapy Intravesical bacillus Calmette–Guerin efficacy maintenance non-muscle-invasive bladder cancer side effects

Biomarkers Tumor Case-Control Studies *DNA Methylation Death-Associated Protein Kinases/*genetics *Genetic Association Studies *Genetic Predisposition to Disease Humans Neoplasm Grading Neoplasm Staging Odds Ratio *Promoter Regions Genetic Publication Bias Risk Urinary Bladder Neoplasms/*epidemiology/*genetics/pathology

Cystectomy/*methods Humans Prognosis *Quality of Life Urinary Bladder Neoplasms/*surgery Bladder cancer Continent urinary diversion Incontinent urinary diversion Quality of life Radical cystectomy

Antineoplastic Combined Chemotherapy Protocols/*therapeutic use Chemotherapy Adjuvant Cisplatin/administration & dosage *Cystectomy/methods Evidence-Based Medicine Humans *Lymph Node Excision Neoadjuvant Therapy/*methods Neoplasm Invasiveness Organ Sparing Treatments/methods Randomized Controlled Trials as Topic Survival Analysis Treatment Outcome Urinary Bladder Neoplasms/mortality/*pathology/*therapy adjuvant chemotherapy bladder cancer bladder-sparing therapy lymph node dissection neoadjuvant chemotherapy radical cystectomy

Adult Aged Aged 80 and over Female Humans Middle Aged *Parity Risk Assessment Urinary Bladder Neoplasms/*epidemiology/etiology/physiopathology Bladder cancer Meta-analysis Parity Women’s health

Meta-Analysis as Topic Polymorphism Genetic oxoguanine glycosylase 1 human [Supplementary Concept]

Aminolevulinate and transurethral resection bladder cancer fluorescence hexaminolevulinate photodynamic diagnosis progression

Cross-Sectional Studies Humans Iran/epidemiology Opium/*adverse effects Risk Factors Smoking/adverse effects Substance-Related Disorders/*epidemiology/physiopathology Urinary Bladder Neoplasms/chemically induced/*epidemiology/physiopathology

*Aminolevulinic Acid Cystectomy/methods Disease-Free Survival Humans Neoplasm Recurrence Local *Photosensitizing Agents Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/diagnostic imaging/*surgery 5-aminolevulinic acid non-muscle invasive bladder cancer photodynamic diagnosis recurrence-free survival transurethral resection

Kaplan-Meier Estimate Neoplasm Grading Neoplasm Metastasis Neoplasm Staging Odds Ratio Prognosis Publication Bias Urinary Bladder Neoplasms/*mortality/*pathology/therapy histological variants squamous differentiation urothelial carcinoma of the bladder including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg employment/affiliation grants or funding consultancies honoraria stock ownership or options expert testimony royalties or patents filed received or pending) are the following: None.

T1期 非肌层浸润性膀胱癌 复发 进展 独立预后因素

非肌层浸润型膀胱肿瘤 绿激光 电切 系统评价 Meta分析 随机对照试验